Article
Evaluation of Q-linea ASTar rapid phenotypic antimicrobial susceptibility testing and potential impact in patients with gram-negative bloodstream infections.
Microbiology spectrum - 7 Jul 2026
Garrett Elizabeth M, Lesher Mark D, Kovtunov Evgenii, Hale Cory M, Pu Meng, Bobenchik April M
Abstract excerpt
Rapid diagnostics can drive antimicrobial stewardship strategies and allow clinicians to develop more precise and individualized treatment pathways. Q-linea ASTar is an FDA-cleared in vitro diagnostic for rapid phenotypic antimicrobial susceptibility testing (AST) system in patients with gram-negative blood stream infections (BSIs). In this study, we report the performance of Q-linea ASTar compared with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
